Blog reports on PPP aimed at improving health status of poorest Central Americans, Mexicans

"At the Inter-American Development Bank's (IDB) recent annual meeting in Panama, the two richest men in the world" -- Mexican businessman and philanthropist Carlos Slim and Bill Gates, co-chair of the Bill & Melinda Gates Foundation – "discussed their contributions to a little-known public-private partnership that aims to improve the health status of the poorest Central Americans and Mexicans -- Salud Mesoamerica 2015 or SM2015," Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development (CGD), writes in the center's "Global Health Policy" blog. "I'm excited to see SM2015 take off because the partnership is testing five innovations in health aid that  -- if successful -- could inform its bigger brothers and sisters at the Global Fund for AIDS, Tuberculosis and Malaria, the GAVI Alliance and beyond," she continues, detailing the five innovations (3/18).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption